A new bill proposed in the New York Assembly, A10104, aims to allow pets with certain medical conditions access to medical grade CBD oil via a licensed veterinarians prescription.
Natural pet supplement sales have nearly doubled between 2008 and 2014, with an increase in sales that have shown the U.S. retail market to be worth $1.6B.
The new bill will provide pets access to hemp derived, high quality, Cannabidiol, or better known to the public as CBD oil. CBD oil has been known as useful in pets treating separation anxiety, epilepsy and other various inflammatory conditions.
Bill A10104 currently rests in the hands of the New York Senate Health Committee for approval.
You may be interested
Canopy Growth’s Tweed Farms Receives Additional Licensing for Cannabis ProductionEditor - September 17, 2018
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) announced this morning that their Tweed Farms cannabis cultivation operation has received an amendment to their license which will approve…
Cash Crop Today Interview with Baylee Sweet from The Harvest Helper Trimmer StoreEditor - September 14, 2018
The Harvest Helper Trimmer store is one of the top resources for cultivators located in the Northwestern part of the United States for all of their automated…
Aurora Cannabis to Enter South American Market with Acquisition of ICC Lab, Inc.Editor - September 11, 2018
Aurora Cannabis Inc.(TSX: ACB) (OTCQB: ACBFF) announced this morning that the company has entered an agreement to acquire the South American cannabis company ICC Labs Inc. (TSX-V:…